Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 5 May 2025

Stock market news: The domestic equity market benchmark indices, Sensex and Nifty 50, saw a minor uptick on Friday, ending off day’s high, as investors resorted to profit-booking at higher levels. Optimism surrounding a potential India-US trade deal, record high April GST collection, and continuous inflow of foreign funds, was offset by potential geopolitical tensions…

Read More

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher

Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal. The acquisition will bolster Sun Pharma’s onco-dermatology portfolio, adding Checkpoint’s recently FDA-approved cancer drug, UNLOXCYT (cosibelimab-ipdl), to its pipeline. The deal, expected to close in the second quarter of the…

Read More
Back To Top